# A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's Safety in Healthy Adults Aged 18 to 55

> **NCT07149415** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 22 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Omaveloxolone
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT07149415
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-02
- **Primary completion:** 2025-10-16
- **Final completion:** 2025-10-16
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07149415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07149415, "A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's Safety in Healthy Adults Aged 18 to 55". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07149415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*